Stock Markets March 4, 2026 12:10 PM

Madrid Stocks Climb as Financials, Telecoms and Consumer Services Drive IBEX 35 Higher

IBEX 35 closes up 2.51% with Indra A hitting an all-time high amid broad market gains

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn

Spanish equities finished higher on Wednesday, with the IBEX 35 rising 2.51% at the close in Madrid. Gains were concentrated in Financial Services & Real Estate, Telecoms & IT and Consumer Services. Notable movers included Amadeus IT, Acerinox and Indra A, while Repsol, Enagas and Laboratorios Farmaceuticos ROVI were among the laggards. Market breadth favored advancers over decliners by a wide margin. Commodities and currency markets saw mixed moves, with gold futures and oil contracts moving in opposite directions and the US Dollar Index futures easing.

Madrid Stocks Climb as Financials, Telecoms and Consumer Services Drive IBEX 35 Higher
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • IBEX 35 closed up 2.51% at the Madrid close, supported by gains in Financial Services & Real Estate, Telecoms & IT and Consumer Services.
  • Top individual performers included Amadeus IT (BME:AMA) +5.56%, Acerinox (BME:ACX) +5.35% and Indra A (BME:IDR) +5.22%; Indra A reached an all-time high.
  • Decliners included Repsol (BME:REP) -2.42%, Enagas (BME:ENAG) -0.99% and Laboratorios Farmaceuticos ROVI (BME:ROVI) -0.61%; advancing issues outnumbered decliners 151 to 43.

Spanish stocks ended the trading day stronger on Wednesday, with the benchmark IBEX 35 finishing up 2.51% at the close in Madrid. Sector strength was led by Financial Services & Real Estate, Telecoms & IT and Consumer Services, which together underpinned the broader advance.

The session's top performers on the IBEX 35 were:

  • Amadeus IT (BME:AMA) - rose 5.56% (up 2.78 points) to close at 52.76.
  • Acerinox (BME:ACX) - gained 5.35% (up 0.65 points) to finish at 12.81.
  • Indra A (BME:IDR) - advanced 5.22% (up 3.20 points) to 64.50; the stock reached all-time highs in the session.

On the downside, the largest decliners included:

  • Repsol (BME:REP) - fell 2.42% (down 0.50 points) to close at 20.20.
  • Enagas (BME:ENAG) - dropped 0.99% (down 0.15 points) to end the day at 14.53.
  • Laboratorios Farmaceuticos ROVI (BME:ROVI) - slipped 0.61% (down 0.50 points) to 81.00.

Market breadth in Madrid favored advancing issues by a margin of 151 to 43, with 19 stocks finishing unchanged. The session featured broad participation across several key sectors, contributing to the IBEX 35's lift.

In commodities trading, Gold Futures for April delivery rose 0.62% (an increase of 31.64) to $5,155.34 a troy ounce. Energy contracts moved lower: Crude oil for April delivery fell 0.17% (down 0.13) to $74.43 a barrel, while the May Brent contract declined 0.20% (down 0.16) to $81.24 a barrel.

Currency and index moves were mixed. EUR/USD stood at 1.16 after a 0.22% move, and EUR/GBP was at 0.87 following a 0.18% move. The US Dollar Index Futures was down 0.24% at 98.77.


Overall, the session in Madrid featured a clear tilt toward gains, with select industrials and technology-linked names among the day’s best performers and energy and utilities among those that lagged.

Risks

  • Concentration of gains in specific sectors - Financial Services & Real Estate, Telecoms & IT and Consumer Services - could expose the market to sector-specific reversals.
  • Energy-related names underperformed during the session, implying sensitivity to moves in oil prices; crude and Brent both declined.
  • Commodities and currency moves were mixed, which can introduce volatility across exporters and importers tied to euro and dollar swings.

More from Stock Markets

Orange Shares Slide as Analyst Skepticism and Macro Strain Weigh on Valuation Oct 9, 2026 Indonesia’s Danantara signals selective market support and cautious AI exposure as it manages large state portfolio Oct 9, 2026 Global watchdog finds big gaps in crisis funding for banks, urges defined public backstops Oct 9, 2026 Spyre Therapeutics Announces Underwritten Offering; Shares Slip in After-Hours Trading Oct 5, 2026 Goldman Lowers Rating on Carl Zeiss Meditec, Citing Valuation-Substance Gap Oct 5, 2026